AskBio in the News
As a world-leading gene therapy company, we are continuously advancing AAV therapeutics, discovering new technology, forging new research collaborations, and adding amazing talent to our team.
AskBio Announces First Patient Dosed in Phase 1 Trial Using AAV Gene Therapy for Congestive Heart Failure
AskBio Launches AskFirst™ Patient Advocacy Program to Educate and Support Participants in Gene Therapy Clinical Trials
AskBio To Present At The 38th Annual J.P. Morgan Healthcare Conference
AskBio Licenses Rights to Selecta Biosciences’ ImmTOR™ Immune Tolerance Platform for the Treatment of Pompe Disease
AskBio Receives “Best Venture Funding” Award from Southeast BIO
SQZ Biotech and AskBio Announce Research Collaboration to Create Immune Tolerization Products for AAV Gene Therapies
Sheila Mikhail, AskBio CEO and Cofounder, Named Springboard Enterprises’ 2019 Northstar Honoree
Editas Medicine and AskBio Enter Strategic Research Collaboration to Explore In Vivo Delivery of Genome Editing Medicines to Treat Neurological Diseases
AskBio Acquires Assets from RoverMed BioSciences, Adds Nanotechnology Precision to Delivery of AAV Gene Therapeutics
Viralgen Receives cGMP Certification from European Medicines Agency
AskBio Applauds Pfizer’s Continuing Investments in Gene Therapy
AskBio Acquires Synpromics Ltd. and Expands its Gene Therapy Technology Portfolio
Selecta Biosciences Combines ImmTOR™ Platform with AskBio’s IndustryLeading Gene Therapy Platform in Strategic Partnership
Statement: Pfizer Phase 1b Clinical Trial Results
Newly Approved Spinal Muscular Atrophy Gene Therapy, Zolgensma®, Validates AskBio Gene Therapy Platform
AskBio Partners with TPG and Vida Ventures
First Patient Dosed with Gene Therapy in Phase 1/2 Study of ACTUS-101 in Patients with Pompe Disease
Asklepios BioPharmaceutical, Inc. Launches New Portfolio Company – Actus Therapeutics, Inc.
AskBio and Columbus Venture Partners Launch Gene Therapy Company Viralgen
NanoCor Announces New Data on Congestive Heart Failure Gene Therapy
Pfizer Aims To Become Industry Leader In Gene Therapy With Acquisition Of Bamboo Therapeutics, Inc.
Baxter to Acquire Chatham Therapeutics
Asklepios BioPharmaceutical Enters Into A Patent License Agreement With Pfizer
Medtronic Makes Equity Investment in NanoCor Therapeutics, Inc.
AskBio Initiates Phase I Trial of Gene Therapy for Heart Failure
Clinical Trials Arena
February 5, 2020
AskFirst: AskBio’s New Gene Therapy Program for Clinical Trial Patients
WRAL TechWire
February 3, 2020
What Duke University Has in Common with Yale, UC Berkeley
Triangle Business Journal
January 6, 2020
Top 10 Young Companies in the Money 2019
GEN Engineering News
January 6, 2020
Triangle-based AskBio to Pay up to $240M for Rights to Use Gene Therapy Technology
WRAL TechWire
December 19, 2019
A New Pair of Genes
NC Economic Development Guide | Business North Carolina
December 16, 2020
2020: New Decade, New Disruption: Cell and Gene Therapy to Eradicate Genetic Diseases
Medical Expo
December 3, 2019
SQZ Biotech and AskBio Collaborate to Overcome AAV Immunogenicity
Manufacturing Chemist
December 3, 2019
R. Jude Samulski: Gene Therapy’s Guiding Force
Pharmaceutical Executive
November 9, 2019
Triangle Life Science Exec Sheila Mikhail Shines as ‘Northstar’ Award Winner
WRAL TechWire
October 24, 2019
Cover Story: AskBio’s Tumultuous Ride to Achieve Unicorn Status
Triangle Business Journal
July 09, 2019
Top 10 Gene Therapy Companies in 2019
Proclinical
June 06, 2019
Meet Sheila Mikhail, Co-Founder of AskBio
Medium
May 28, 2019
How This Promising Gene Therapy for a Rare Neuromuscular Disease Was Fueled by Passionate Parents and a Dog
Genetic Literacy Project
May 7, 2019
AskBio Gets $235 Million in Gene Therapy Support
WRAL TechWire
April 12, 2019
AskBio Banks $235 Million Investment To Accelerate Growth
Triangle Business Journal
April 11, 2019
TPG, VIDA Back AskBio in $235 Million Round
BioCentury
April 11, 2019
AskBio’s $235 Million Financing Provides Clues to the Direction of Gene Therapy Investment
STAT
April 11, 2019
M&A Wrap
Mergers & Acquisitions
April 11, 2019
AskBio Reels in $235M to Ramp Up Gene Therapy Clinical Trials, Manufacturing
FierceBiotech
April 11, 2019
Jude Samulski Named to North Carolina Power 100
Business North Carolina
January 29, 2019
Check out the conferences and events we are attending and where we are speaking.
11th Open Scientific EIP Symposium on Immunogenicity of Biopharmaceuticals | Lisbon
Alliance for Regenerative Medicine (ARM) | 2020 Cell & Gene Therapies State of the Industry
Springboard Enterprises’ 13th Annual Winners’ Circle Dinner
Chardan Genetic Medicines Conference
Cell & Gene Meeting on the Mesa
Harvard Career Fair
National Limb Girdle Muscular Dystrophy Conference
Parent Project Muscular Dystrophy, 25th Annual Conference
American Society of Gene & Cell Therapy, 22nd Annual Conference
Gene Therapy Panel (Alliance for Regenerative Medicine)
The Growing Promise of Gene Therapy Approaches
Media Inquiries
We take pride in our relationships with media representatives. Our scientific experts are always available if needed for interviews and their insights.
Media Contact:
Robin Fastenau, Vice President, Communications
